RecruitingNCT06337383

Study of the Prevalence of Autistic Traits in Angelman Syndrome

Study of the Prevalence of Autistic Traits in Angelman Syndrome, the Correlation With Cognitive Level, Epilepsy, With Socio-communication Skills and Parenting Styles


Sponsor

IRCCS Eugenio Medea

Enrollment

46 participants

Start Date

Mar 15, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational cross-sectional study is to establish the prevalence of autism spectrum disorder in children and adolescents with Angelman syndrome. The main questions it aims to answer are: * which clinical variables differentiate AS patients with and without Autism Spectrum Disorder between genetics, epilepsy, pharmacotherapy, behavioural problems, parenting style and parents' perceived stress. * which clinical variables differentiate parenting styles and levels of perceived stress. Data from neuropsychological, speech therapy and physiotherapeutic assessments are collected during regular clinical follow-ups, regarding: cognitive development ("Bayely Scales of Infant Development-III", Cognitive Scale) and adaptive behaviour; Autism and Autism Spectrum Disorder ("Autism Diagnostic Observational Schedule-2"); parental stress and parenting styles; social-communicative skills; motor development.


Eligibility

Min Age: 4 YearsMax Age: 14 Years

Inclusion Criteria2

  • genetically confirmed diagnosis of Angelman Syndrome
  • chronological age between 4-15 years

Exclusion Criteria3

  • genetic examination pending report
  • mental age lower than 12 months
  • brain injury acquired in the peri- or postnatal period

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

I.R.C.C.S. "E.Medea"

Conegliano, Treviso, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06337383


Related Trials